Topotecan Vs. Topotecan + Etoposide Vs.Topotecan + Gemcitabine in Ovarian Cancer Therapy

NCT00312988 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

450

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Hycamtin
DRUG: Gemcitabine

Sponsor

North Eastern German Society of Gynaecological Oncology